Herzliya Medical Center
Tel: +972-9-959-4888
09:00-18:00
Professor Peled graduated from the Faculty of Medicine in Haifa University the “Technion” in 1994. Specializing in the field of lung cancer. Professor Peled received training in the United States, at the University of Colorado. Professor Peled is one of the leading experts in the field of lung cancer not only in Israel but also in the world. Professor Peled is the author of hundreds of published articles on the topic of chronic, inflammatory and oncological diseases of the lungs.
A: Radiation is recommended when the tumor is still local. Once the tumor has spread – systematic treatment is necessary and chemotherapy is prescribed.
A: There are many clinical trials for lung cancer and they can offer you new and untested treatment methods. However, it doesn’t necessarily mean that the experimental treatment will be better or effective.
A: Second-hand smoke is very dangerous and should be avoided.
A: In the last few years, several treatments have been developed for metastatic lung cancer, which can offer long-term benefits with minimal side effects. You should get a full genetic analysis of the tumor so that your oncologist can offer you effective treatment.
A: Yes, asthma does have different stages of severity. It won’t necessarily get worse, but if it does you should contact your treating physician so that he can correct your treatment plan.
A: This is a complicated condition. Today there are new therapies that may offer long term benefit and even with minimal adverse events. Therefore, you should consult with a medical oncologist about possible therapies.
lung cancer Q&AA: Such therapy is sometimes recommended to make the tumor smaller and to allow a better operation.
A: The prognosis depends on the stage, the histology and the genetic profile of the disease and the response to therapy. considering all those factors may provide an accurate prognosis. A second opinion, however, is always advised.
A: A family history increases the risk of lung cancer. However, there is no recommendation for a screening test for this population yet.
A: Lung lesions may be benign or malignant; upon the appearance on the CT scan, we may evaluate the risk for malignancy.
A: Lung cancer is more common in patients with chronic lung diseases. However, it doesn’t mean that a chronic lung disease evolves into cancer.
A: Many people live with one lung. Your post-operative functions should be evaluated prior to the surgery to make sure you can tolerate the surgery. The void left after a lung removal is usually filled by the inflation of the other lung, and fluids.
A: In general, those medications are safe and were approved considering long-term therapy. Some inhalers may cause eye complications, therefore require a routine check-up after a certain amount of time.
A: Of course. Asthmatic patients may suffer from a hyperacute condition. Although this is a rare situation, it might occur.
A: You should discuss your case with an experienced thoracic surgeon.
HMC will continue hosting live Q&A sessions with leading physicians every month, to better serve our patients and the public. If you have any questions In case you have any other question regarding lung diseases, lung cancer, and wish to receive a medical quote, do not hesitate to contact us.